Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP)-RFA-CE23-004: Research Grants for Preventing Violence and Violence Related Injury; Amended Notice of Closed Meeting, 10905 [2023-03565]

Download as PDF Federal Register / Vol. 88, No. 35 / Wednesday, February 22, 2023 / Notices The meeting is being amended to change the meeting date and should read as follows: Date: April 21, 2023. Time: 10 a.m.–6 p.m., EDT. The meeting is closed to the public. FOR FURTHER INFORMATION CONTACT: Natalie Brown, M.P.H., Scientific Review Officer, National Center for Chronic Disease Prevention and Health Promotion, CDC, 4770 Buford Highway, Mailstop S107–8, Atlanta, Georgia 30341–3717; Telephone: (404) 639– 4601; Email: NBrown3@cdc.gov. The Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Kalwant Smagh, Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention. [FR Doc. 2023–03568 Filed 2–21–23; 8:45 am] DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention lotter on DSK11XQN23PROD with NOTICES1 Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP)—RFA–CE23– 004: Research Grants for Preventing Violence and Violence Related Injury; Amended Notice of Closed Meeting Notice is hereby given of a change in the meeting of the Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP)—RFA– CE23–004: Research Grants for Preventing Violence and Violence Related Injury; March 28–29, 2023, 8:30 a.m.–5:30 p.m., EDT, Videoconference, in the original FRN. The meeting was published in the Federal Register on January 20, 2023, Volume 88, Number 13, page 3743. The meeting is being amended to remove the second day and should read as follows: Date: March 29, 2023 Time: 8:30 a.m.–5:00 p.m. (EDT) Place: Videoconference. The meeting is closed to the public. FOR FURTHER INFORMATION CONTACT: Aisha L. Wilkes, M.P.H., Scientific Review Officer, National Center for 19:42 Feb 21, 2023 Jkt 259001 Kalwant Smagh, Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention. 1905 Willowdale Road, Morgantown, West Virginia 26506; Telephone: (304) 285–5951; Email: MGoldcamp@cdc.gov. The Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Kalwant Smagh, Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention. [FR Doc. 2023–03567 Filed 2–21–23; 8:45 am] BILLING CODE 4163–18–P [FR Doc. 2023–03565 Filed 2–21–23; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Notice of Closed Meeting BILLING CODE 4163–18–P VerDate Sep<11>2014 Injury Prevention and Control, CDC, 4770 Buford Highway NE, Mailstop S106–9, Atlanta, Georgia 30341, Telephone: (404) 639–6473; Email: AWilkes@cdc.gov. The Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. 10905 Frm 00037 Fmt 4703 Sfmt 4703 Recharter for Advisory Council on Blood Stem Cell Transplantation Health Resources and Services Administration (HRSA), Department of Health and Human Services. ACTION: Notice. AGENCY: Pursuant to 5 U.S.C. 1009(d), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended, and the Determination of the Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, CDC, pursuant to Public Law 92–463. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP)— RFA OH–23–004, NIOSH Miner Safety and Health Program—Western Mining States Review; and RFA OH–23–005, NIOSH Robotic Mining Review. Date: May 25, 2023. Time: 1 p.m.–5 p.m., EDT. Place: Teleconference. Agenda: To review and evaluate grant applications. FOR FURTHER INFORMATION CONTACT: Michael Goldcamp, Ph.D., Scientific Review Officer, Office of Extramural Programs, National Institute for Occupational Safety and Health, CDC, PO 00000 Health Resources and Services Administration In accordance with the Federal Advisory Committee Act (FACA), the Department of Health and Human Services is hereby giving notice that the Advisory Council on Blood Stem Cell Transplantation (ACBSCT) has been rechartered. The effective date of the recharter is February 19, 2023. FOR FURTHER INFORMATION CONTACT: Shelley Tims Grant (Designated Federal Officer); HRSA Division of Transplantation, HRSA, 5600 Fishers Lane, 08W67, Rockville, Maryland 20857; 301–443–8036; or sgrant@ hrsa.gov. SUPPLEMENTARY INFORMATION: The ACBSCT advises, assists, consults with, and makes recommendations to the Secretary of Health and Human Services, acting through the HRSA Administrator, on matters related to the activities of the C.W. Bill Young Cell Transplantation Program and National Cord Blood Inventory and other matters of significance concerning the activities under section 379 of the Public Health Service Act (42 U.S.C. 274k). The ACBSCT shall provide a consolidated, comprehensive source of expert, unbiased analysis, and recommendations to the Secretary of Health and Human Services on the latest advances in the science of blood SUMMARY: E:\FR\FM\22FEN1.SGM 22FEN1

Agencies

[Federal Register Volume 88, Number 35 (Wednesday, February 22, 2023)]
[Notices]
[Page 10905]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-03565]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel (SEP)--RFA-CE23-004: Research Grants for Preventing 
Violence and Violence Related Injury; Amended Notice of Closed Meeting

    Notice is hereby given of a change in the meeting of the Disease, 
Disability, and Injury Prevention and Control Special Emphasis Panel 
(SEP)--RFA-CE23-004: Research Grants for Preventing Violence and 
Violence Related Injury; March 28-29, 2023, 8:30 a.m.-5:30 p.m., EDT, 
Videoconference, in the original FRN. The meeting was published in the 
Federal Register on January 20, 2023, Volume 88, Number 13, page 3743.
    The meeting is being amended to remove the second day and should 
read as follows:

Date: March 29, 2023
Time: 8:30 a.m.-5:00 p.m. (EDT)
Place: Videoconference.

    The meeting is closed to the public.

FOR FURTHER INFORMATION CONTACT: Aisha L. Wilkes, M.P.H., Scientific 
Review Officer, National Center for Injury Prevention and Control, CDC, 
4770 Buford Highway NE, Mailstop S106-9, Atlanta, Georgia 30341, 
Telephone: (404) 639-6473; Email: [email protected].
    The Director, Strategic Business Initiatives Unit, Office of the 
Chief Operating Officer, Centers for Disease Control and Prevention, 
has been delegated the authority to sign Federal Register notices 
pertaining to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and Prevention and 
the Agency for Toxic Substances and Disease Registry.

Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief 
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2023-03565 Filed 2-21-23; 8:45 am]
BILLING CODE 4163-18-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.